Peripheral complement interactions with amyloid β peptide in Alzheimer's disease: 2. Relationship to amyloid β immunotherapy
- 26 July 2017
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 14 (2), 243-252
- https://doi.org/10.1016/j.jalz.2017.04.015
Abstract
Introduction: Our previous studies have shown that amyloid b peptide (Ab) is subject to complement-mediated clearance from the peripheral circulation, and that this mechanism is deficient in Alzheimer's disease. The mechanism should be enhanced by Ab antibodies that form immune complexes (ICs) with Ab, and therefore may be relevant to current Ab immunotherapy approaches. Methods: Multidisciplinary methods were employed to demonstrate enhanced complement-mediated capture of Ab antibody immune complexes compared with Ab alone in both erythrocytes and THP1-derived macrophages. Results: Ab antibodies dramatically increased complement activation and opsonization of Ab, followed by commensurately enhanced Ab capture by human erythrocytes and macrophages. These in vitro findings were consistent with enhanced peripheral clearance of intravenously administered Ab antibody immune complexes in nonhuman primates. Discussion: Together with our previous results, showing significant Alzheimer's disease deficits in peripheral Ab clearance, the present findings strongly suggest that peripheral mechanisms should not be ignored as contributors to the effects of Ab immunotherapy. (C) 2017 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.Funding Information
- National Institutes of Health (RO1AG07367)
- National Institutes of Health (RO1AG039750)
This publication has 41 references indexed in Scilit:
- Open questions for Alzheimer’s disease immunotherapyAlzheimer's Research & Therapy, 2014
- Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformationScientific Reports, 2013
- Is abeta a sufficient biomarker for monitoring anti-abeta clinical studies? A critical reviewFrontiers in Aging Neuroscience, 2013
- Association of the CR1 polymorphism with late-onset Alzheimer's disease in Chinese Han populations: A meta-analysisNeuroscience Letters, 2012
- A coding variant in CR1 interacts with APOE-ɛ4 to influence cognitive declineHuman Molecular Genetics, 2012
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseNature Genetics, 2009
- Insights into the mechanisms of action of anti‐Aβ antibodies in Alzheimer's disease mouse modelsThe FASEB Journal, 2006
- Amyloid-β Peptides Interact with Plasma Proteins and Erythrocytes: Implications for Their Quantitation in PlasmaBiochemical and Biophysical Research Communications, 2000
- Cerebrovascular Accumulation and Increased Blood‐Brain Barrier Permeability to Circulating Alzheimer's Amyloid β Peptide in Aged Squirrel Monkey with Cerebral Amyloid AngiopathyJournal of Neurochemistry, 1998
- Central nervous system complications of diabetes mellitus — a perspective from the blood–brain barrierBrain Research Reviews, 1997